CA1018456A - Prolonged release lozenges - Google Patents

Prolonged release lozenges

Info

Publication number
CA1018456A
CA1018456A CA174,779A CA174779A CA1018456A CA 1018456 A CA1018456 A CA 1018456A CA 174779 A CA174779 A CA 174779A CA 1018456 A CA1018456 A CA 1018456A
Authority
CA
Canada
Prior art keywords
prolonged release
release lozenges
lozenges
prolonged
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA174,779A
Other versions
CA174779S (en
Inventor
Hans Lowey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA1018456A publication Critical patent/CA1018456A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
    • C08L1/08—Cellulose derivatives
    • C08L1/26—Cellulose ethers
    • C08L1/28—Alkyl ethers
CA174,779A 1972-06-26 1973-06-22 Prolonged release lozenges Expired CA1018456A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26645272A 1972-06-26 1972-06-26

Publications (1)

Publication Number Publication Date
CA1018456A true CA1018456A (en) 1977-10-04

Family

ID=23014648

Family Applications (1)

Application Number Title Priority Date Filing Date
CA174,779A Expired CA1018456A (en) 1972-06-26 1973-06-22 Prolonged release lozenges

Country Status (8)

Country Link
JP (1) JPS4954519A (en)
BR (1) BR7304698D0 (en)
CA (1) CA1018456A (en)
DE (1) DE2332484C2 (en)
DK (1) DK146434C (en)
FR (1) FR2190409B1 (en)
GB (1) GB1430684A (en)
NL (1) NL183808C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226849A (en) 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4259314A (en) 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4357469A (en) 1979-06-14 1982-11-02 Forest Laboratories, Inc. Carrier base material for prolonged release therapeutic compositions

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43437B (en) * 1976-05-05 1989-08-31 Lowey Hans Process for obtaining tablets containing an active component with long lasting effect
FR2455459A1 (en) * 1979-05-02 1980-11-28 Sertog Carboxy:methylcellulose matrix for slow release of volatile cpd. - contains tri:ethanolamine, stearin and an alcohol e.g. cetyl is esp. useful for perfumes, insect repellents eczema treatment etc.
CH652025A5 (en) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmaceutical preparation.
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
GB2133284A (en) * 1983-01-07 1984-07-25 English Grains Limited Resilient pharmaceutical unit for treating mouth ulcers
JPH0729927B2 (en) * 1983-04-09 1995-04-05 日研化学株式会社 Theophylline sustained release formulation
JPH0662404B2 (en) * 1983-06-14 1994-08-17 シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド Controlled-release naproxen and naproxen sodium tablets
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
US4855143A (en) * 1986-04-04 1989-08-08 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
WO1992001453A1 (en) * 1990-07-19 1992-02-06 Otsuka Pharmaceutical Co., Ltd. Solid preparation
JPH07112934A (en) * 1993-10-15 1995-05-02 Taiyo Yakuhin Kogyo Kk Sustained release preparation of pentoxyphylline and its production
US6787156B1 (en) 1994-02-23 2004-09-07 Bm Research A/S Controlled release composition
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
CA2327685C (en) 1998-04-03 2008-11-18 Bm Research A/S Controlled release composition
US20040253310A1 (en) 2001-09-21 2004-12-16 Gina Fischer Morphine polymer release system
EP2957281A1 (en) 2001-09-21 2015-12-23 Egalet Ltd. Polymer release system
EP1545469A1 (en) * 2002-09-24 2005-06-29 Akzo Nobel N.V. Method to improve pharmaceutical tablets having a matrix of cellulose ether
WO2004041252A1 (en) 2002-11-08 2004-05-21 Egalet A/S Controlled release carvedilol compositions
JP4989217B2 (en) 2003-03-26 2012-08-01 エガレット エイ／エス Matrix composition for controlled delivery of drug substance
ES2360102T3 (en) 2003-03-26 2011-05-31 Egalet A/S SYSTEM FOR CONTROLLED RELEASE OF MORPHINE.
NZ580972A (en) 2007-06-04 2012-02-24 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
CA2751667C (en) 2009-02-06 2016-12-13 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
NZ597283A (en) 2009-06-24 2013-07-26 Egalet Ltd Controlled release formulations
WO2014006004A1 (en) 2012-07-06 2014-01-09 Egalet Ltd. Abuse deterrent pharmaceutical compositions for controlled release

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1171691A (en) * 1967-02-24 1969-11-26 Forest Laboratories Lond-Acting Oral Carrier
GB1279214A (en) * 1970-01-22 1972-06-28 Forest Laboratories Long-acting oral carrier

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226849A (en) 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4357469A (en) 1979-06-14 1982-11-02 Forest Laboratories, Inc. Carrier base material for prolonged release therapeutic compositions
US4259314A (en) 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals

Also Published As

Publication number Publication date
GB1430684A (en) 1976-03-31
DK146434C (en) 1984-03-19
BR7304698D0 (en) 1974-09-24
NL183808B (en) 1988-09-01
FR2190409B1 (en) 1977-04-15
NL183808C (en) 1989-02-01
JPS4954519A (en) 1974-05-27
DK146434B (en) 1983-10-10
DE2332484A1 (en) 1974-01-10
NL7308859A (en) 1973-12-28
FR2190409A1 (en) 1974-02-01
DE2332484C2 (en) 1984-11-15

Similar Documents

Publication Publication Date Title
CA1018456A (en) Prolonged release lozenges
AU5439373A (en) Pillow-doll combination
AU462348B2 (en) Saf-t-jet
AU467469B2 (en) Trifluoromethylmercaptoacetamindocephalosphorins
AU454372B2 (en) Childsafe actuator-overcap
AU469305B2 (en) Deipenylyl-alkanoylaminopyridine
AU466359B2 (en) Clutch
AU468139B2 (en) Bin-lifting mechanism
CA964212A (en) Clutch
AU466344B2 (en) Cycloalkyllactamimides
AU468159B2 (en) 5-aroyl-furans
AU4986472A (en) Tablets
AU467526B2 (en) Pyronorifamycins
AU468236B2 (en) 2-acyl-5-nitrothiazoles
AU468599B2 (en) 15-oxasteroids
CA917075A (en) Sustained release tablets
AU5834673A (en) Novel trialkoxybenzoylpeptides
CA904184A (en) Brake
CA908073A (en) Brake
CA914541A (en) Soap-sulphonate tablets
CA907455A (en) Soap-sulphate tablets
CA900378A (en) Brake mechanism
CA913541A (en) Brake mechanism
CA916073A (en) Brake mechanism
CA899940A (en) Lock-alarm combination